/ AVXL
Why Anavex (AVXL) Is Down 50% Today: EMA Rejects Alzheimer’s Drug Progress
Anavex stock plunged 50% in premarket trading after European regulators issued a negative vote on its Alzheimer’s drug blarcamesine.
November 14, 2025Anavex Life Sciences (AVXL) Reports Net Loss of $10.1M in Q4
Anavex Life Sciences Corp. reported its Q4 earnings showing signs of improving margins.
November 27, 2023